Axq Capital »

ADC Therapeutics SA shares owned by Axq Capital

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Axq Capital from 13F filings

Historical chart of Axq Capital investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Axq Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Axq Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $57k 16k 3.53

More positions owned by Axq Capital

Bellring Brands Common Stock (BRBR)
Rocket Cos Com Cl A (RKT)
O'reilly Automotive (ORLY)
UnitedHealth (UNH)
Microsoft Corporation (MSFT)
Xylem (XYL)
Sofi Technologies (SOFI)
Duolingo Cl A Com (DUOL)
Marsh & McLennan Companies
Honeywell International (HON)
Blackrock (BLK)
Stryker Corporation (SYK)
NVIDIA Corporation (NVDA)
Interactive Brokers Group In Com Cl A (IBKR)
Lennar Corp Cl A (LEN)

View all positions for Axq Capital

Top funds holding ADC Therapeutics SA

Redmile Group
Prosight Management
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
BlackRock
Eventide Asset Management
Goldman Sachs Group
State Street Corporation
TCG Crossover Management
Lynx1 Capital Management
Vanguard Group
Geode Capital Management
Platinum Investment Mangement
Citadel Advisors

View all funds holding ADC Therapeutics SA